Eisai Inc. – Differentiated Thyroid Cancer

Access Program Information

This Expanded Access Program (EAP) consists of a Prerandomization Phase and a Randomization
Phase. Only subjects with radioiodine-refractory DTC who fulfill the eligibility criteria
will be treated. These subjects will be treated until progression of disease or
unacceptable toxicity.